2025/12/15 by Patrick H Dessein, Mpoti Seboka, Ahmed Solomon · 1 voice
Immunology and Microbiology · Medicine · #Psoriasis: Treatment and Pathogenesis #Spondyloarthritis Studies and Treatments #Rheumatoid Arthritis Research and Therapies
paper · pdf · doi:10.3899/jrheum.2025-1216
openalex publication_date 2025/12/15 · openalex created_date 2025/12/15 · openalex updated_date 2026/07/31
Psoriatic disease (PsD) comprises psoriasis (PsO) and psoriatic arthritis (PsA), which are chronic immune-mediated inflammatory diseases (IMIDs).<sup>1</sup> In mostly high-income White populations, the prevalence of PsO is 2% to 3% and that of PsA 0.1% to 1%. The prevalence of PsD is reportedly somewhat lower in low-income populations, including in Asian and African people.<sup>2</sup>